Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
Stock Information for Processa Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.